Recce Pharmaceuticals Secures $8M Placement and Launches $3M Entitlement Offer to Shareholders
$8 million commitments received in a strongly supported placement to new and existing institutional investors $3 million entitlement offer at the...
$8 million commitments received in a strongly supported placement to new and existing institutional investors $3 million entitlement offer at the...
RESEARCH TRIANGLE PARK, N.C., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Science 37 announced today that it has been recognized in...
The life science and biotech commercial veteran will lead the company's growth strategy Darcy Birse - Chief Commercial Officer, Culture...
Highlights: Record monthly Travelan® salesAustralian sales of A$1.18 M in August 2023 (7984% increase on August 2022 sales)MELBOURNE, Australia, Sept....
LONDON, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focusing on the discovery and development...
UK site now set for clinical production of adeno-associated virus (AAV) vectors for gene therapyHighly experienced team ready to support...
Roche Venture Fund joins existing major investors Epidarex Capital, Sofinnova Partners and BioGeneration VenturesSeptember 13, 2023: Glasgow, Scotland – Mironid,...
MONTREAL, Sept. 13, 2023 (GLOBE NEWSWIRE) -- DalCor Pharmaceuticals today announced the closing of the company’s Series D financing round...
SAN DIEGO, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the...
JUPITER, Fla., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology...
Live broadcast of webinar on Tuesday, September 19 beginning at 11:30 am ETVANCOUVER, British Columbia, Sept. 12, 2023 (GLOBE NEWSWIRE)...
Significant progress made and well positioned for future growthLONDON, UK / ACCESSWIRE / September 13, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF),...
RANCHO CUCAMONGA, CA / ACCESSWIRE / September 13, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar") today announced the pricing of...
VANCOUVER, BC / ACCESSWIRE / September 12, 2023 / Lucy Scientific Discovery Inc. (NASDAQ:LSDI), a publicly traded company focused on...
Catherine Burzik Appointed Interim Chief Executive Officer Geoffrey Gillespie Appointed Interim Chief Financial Officer Puja Leekha Appointed Interim Chief Legal...
Toronto, Ontario--(Newsfile Corp. - September 12, 2023) - GoodCap Pharmaceuticals Inc. ("GoodCap" or the "Company"), a leading biopharmaceutical company focused...
Cholera is an acute diarrheal illness caused by infection of the intestine with the bacterium Vibrio choleraeJaguar intends to pursue...
Company reaches major strategic inflection point, with operations and revenue ramp-up underwayInaugural 2026 guidance introduced; target to achieve:More than $180...
LAVAL, QE / ACCESSWIRE / September 12, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is pleased to announce that following...
Appointments strengthen the leadership team and deepen expertise in drug discovery, oncology research, and strategic partnershipsDr. Brian Jones appointed to...